{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T23:08:00Z","timestamp":1740179280863,"version":"3.37.3"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,10,20]],"date-time":"2023-10-20T00:00:00Z","timestamp":1697760000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,10,20]],"date-time":"2023-10-20T00:00:00Z","timestamp":1697760000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Patient Rep Outcomes"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Pediatric asthma has been identified by regulators, clinicians, clinical trial sponsors, and caregivers as an area in need of novel fit-for-purpose clinical outcome assessments (COAs) developed in accordance with the U.S. Food and Drug Administration\u2019s (FDA\u2019s) regulatory guidance for evaluating clinical benefit in treatment trials. To address this gap, the Patient-Reported Outcome (PRO) Consortium\u2019s Pediatric Asthma Working Group has continued development of 2 COAs to assess asthma signs and symptoms in pediatric asthma clinical trials to support efficacy endpoints: a PRO measure, the <jats:italic>Pediatric Asthma Diary\u2014Child<\/jats:italic> (<jats:italic>PAD-C<\/jats:italic>) for children 8\u201311 years old (y.o.) and an observer-reported outcome measure, the <jats:italic>Pediatric Asthma Diary-Observer<\/jats:italic> (<jats:italic>PAD\u2014O)<\/jats:italic> for caregivers of children 4\u201311 y.o. This qualitative research aimed to generate evidence regarding the content validity of the <jats:italic>PAD-C<\/jats:italic> and <jats:italic>PAD-O<\/jats:italic>.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Semi-structured combined concept elicitation and cognitive interviews were conducted with a diverse sample of U.S. participants (15 children 8\u201311 y.o. and 30 caregivers of children 4\u201311 y.o.). All children had clinician-diagnosed mild to severe asthma. Interviews explored the experience of pediatric asthma and assessed the understanding and relevance of both measures. Interviews were conducted across 3 iterative rounds to allow for modifications.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Concept elicitation findings demonstrated that the core sign\/symptom and impact concepts assessed in the <jats:italic>PAD-C<\/jats:italic> (cough, hard to breathe, out of breath, wheezing, chest tightness, and nighttime awakenings\/symptoms) and <jats:italic>PAD-O<\/jats:italic> (cough, difficulty breathing, short of breath, wheezing, and nighttime awakenings\/signs) correspond to those most frequently reported by participants; concept saturation was achieved. All <jats:italic>PAD-C<\/jats:italic> and <jats:italic>PAD-O<\/jats:italic> instructions and core items were well understood and considered relevant by most participants. Feedback from participants, the Pediatric Asthma Working Group, advisory panel, and FDA supported modifications to the measures, including addition of 1 new item to both measures and removal of 1 caregiver item.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Findings provide strong support for the content validity of both measures. The cross-sectional measurement properties of both measures and their user experience and feasibility in electronic format will be assessed in a future quantitative pilot study with qualitative exit interviews, intended to support the reliability, construct validity, final content, and, ultimately, FDA qualification of the measures.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s41687-023-00639-y","type":"journal-article","created":{"date-parts":[[2023,10,20]],"date-time":"2023-10-20T16:01:46Z","timestamp":1697817706000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Assessing asthma symptoms in children: qualitative research supporting the development of the Pediatric Asthma Diary\u2014Child (PAD-C) and Pediatric Asthma Diary\u2014Observer (PAD-O)"],"prefix":"10.1186","volume":"7","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7077-2183","authenticated-orcid":false,"given":"Helena","family":"Bradley","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claire","family":"Trennery","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amy M.","family":"Jones","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aoife","family":"Lydon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frances","family":"White","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rebecca","family":"Williams-Hall","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rob","family":"Arbuckle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erin","family":"Tomaszewski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vivian H.","family":"Shih","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John","family":"Haughney","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amanda","family":"Eisen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tonya","family":"Winders","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephen Joel","family":"Coons","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sonya","family":"Eremenco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"the Patient-Reported Outcome Consortium\u2019s Pediatric Asthma Working Group","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Linda","family":"Nelsen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maggie","family":"Tabberer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria","family":"Mattera","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Asha","family":"Lehane","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lucy","family":"Morgan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jerry","family":"Krishnan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,10,20]]},"reference":[{"key":"639_CR1","unstructured":"Global Initiative for Asthma (2021) Global Strategy for Asthma Management and Prevention."},{"key":"639_CR2","unstructured":"World Health Organization (2021) Asthma. https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/asthma. Accessed 11 Jan 2022"},{"key":"639_CR3","unstructured":"American Academy of Allergy and Asthma Immunology (2022) Childhood Asthma (Pediatric Asthma) Defined. https:\/\/www.aaaai.org\/Tools-for-the-Public\/Allergy,-Asthma-Immunology-Glossary\/Childhood-Asthma-(Pediatric-Asthma)-Defined. Accessed 11 Jan 2022"},{"issue":"1","key":"639_CR4","doi-asserted-by":"publisher","first-page":"6","DOI":"10.5334\/aogh.2416","volume":"85","author":"D Serebrisky","year":"2019","unstructured":"Serebrisky D, Wiznia A (2019) Pediatric asthma: a global epidemic. Ann Glob Health 85(1):6","journal-title":"Ann Glob Health"},{"key":"639_CR5","doi-asserted-by":"publisher","first-page":"186","DOI":"10.3389\/fped.2018.00186","volume":"6","author":"G Ferrante","year":"2018","unstructured":"Ferrante G, La Grutta S (2018) The burden of pediatric asthma. Front Pediatr 6:186","journal-title":"Front Pediatr"},{"issue":"2","key":"639_CR6","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1378\/chest.113.2.272","volume":"113","author":"JG Teeter","year":"1998","unstructured":"Teeter JG, Bleecker ER (1998) Relationship between airway obstruction and respiratory symptoms in adult asthmatics. Chest 113(2):272\u2013277","journal-title":"Chest"},{"issue":"8","key":"639_CR7","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1053\/rmed.2000.0814","volume":"94","author":"E St\u00e5hl","year":"2000","unstructured":"St\u00e5hl E (2000) Correlation between objective measures of airway calibre and clinical symptoms in asthma: a systematic review of clinical studies. Respir Med 94(8):735\u2013741","journal-title":"Respir Med"},{"issue":"6","key":"639_CR8","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1016\/S1081-1206(10)60117-2","volume":"102","author":"SQ Davis","year":"2009","unstructured":"Davis SQ, Permutt Z, Permutt S, Naureckas ET, Bilderback AL, Rand CS, Stein BD, Krishnan JA (2009) Perception of airflow obstruction in patients hospitalized for acute asthma. Ann Allergy Asthma Immunol 102(6):455\u2013461","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"4","key":"639_CR9","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1016\/j.jval.2013.04.004","volume":"16","author":"LS Matza","year":"2013","unstructured":"Matza LS, Patrick DL, Riley AW, Alexander JJ, Rajmil L, Pleil AM, Bullinger M (2013) Pediatric patient-reported outcome instruments for research to support medical product labeling: report of the ISPOR PRO good research practices for the assessment of children and adolescents task force. Value Health 16(4):461\u2013479","journal-title":"Value Health"},{"key":"639_CR10","unstructured":"US Department of Health and Human Services Food and Drug Administration (2009) Guidance for industry: patient-reported outcome measures: use in medical product development to support labeling claims."},{"issue":"1","key":"639_CR11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s41687-022-00432-3","volume":"6","author":"M Clark","year":"2022","unstructured":"Clark M, Romano C, Olayinka-Amao O, Whalley D, Crawford R, Pathak P, Brindicci C, Garg K, Kordy K, Everhard F (2022) Development and content validation of a self-completed, electronic Pediatric Asthma Symptom Diary. J Patient-Rep Outcomes 6(1):1\u201313","journal-title":"J Patient-Rep Outcomes"},{"key":"639_CR12","unstructured":"US Department of Health and Human Services Food and Drug Administration (2022) Patient-focused drug development: selecting, developing, or modifying fit-for-purpose clinical outcome assessments: guidance for industry, food and drug administration staff, and other stakeholders."},{"issue":"4","key":"639_CR13","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1016\/j.jval.2016.01.007","volume":"19","author":"A Gater","year":"2016","unstructured":"Gater A, Nelsen L, Fleming S, Lundy JJ, Bonner N, Hall R, Marshall C, Staunton H, Krishnan JA, Stoloff S (2016) Assessing asthma symptoms in adolescents and adults: qualitative research supporting development of the asthma daily symptom diary. Value Health 19(4):440\u2013450","journal-title":"Value Health"},{"issue":"5","key":"639_CR14","doi-asserted-by":"publisher","first-page":"1249","DOI":"10.1016\/j.jaip.2021.11.026","volume":"10","author":"A Gater","year":"2022","unstructured":"Gater A, Nelsen L, Coon CD, Eremenco S, O\u2019Quinn S, Khan AH, Eckert L, Staunton H, Bonner N, Hall R (2022) Asthma daytime symptom diary (ADSD) and asthma nighttime symptom diary (ANSD): measurement properties of novel patient-reported symptom measures. J Allergy Clin Immunol Pract 10(5):1249\u20131259","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"5","key":"639_CR15","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1038\/clpt.2011.203","volume":"90","author":"S Coons","year":"2011","unstructured":"Coons S, Kothari S, Monz B, Burke L (2011) The patient-reported outcome (PRO) consortium: filling measurement gaps for PRO end points to support labeling claims. Clin Pharmacol Ther 90(5):743\u2013748","journal-title":"Clin Pharmacol Ther"},{"issue":"3","key":"639_CR16","doi-asserted-by":"publisher","first-page":"A179","DOI":"10.1016\/j.jval.2014.03.1043","volume":"17","author":"L Nelsen","year":"2014","unstructured":"Nelsen L, Currie B, Norquist J, Peter S, Vernon M (2014) Pediatric asthma symptoms: assessments by subjects and caregivers. Value Health 17(3):A179","journal-title":"Value Health"},{"key":"639_CR17","unstructured":"US Department of Health and Human Services Food and Drug Administration (2020) Qualification process for drug development tools: guidance for industry and FDA staff."},{"key":"639_CR18","unstructured":"US Department of Health and Human Services Food and Drug Administration (2022) Patient-focused drug development: methods to identify what is important to patients: guidance for industry, food and drug administration staff, and other stakeholders."},{"key":"639_CR19","unstructured":"US Department of Health and Human Services Food and Drug Administration (2020) Patient-focused drug development: collecting comprehensive and representative input: guidance for industry, food and drug administration staff, and other stakeholders."},{"issue":"3","key":"639_CR20","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1002\/pbc.20096","volume":"43","author":"PC Nathan","year":"2004","unstructured":"Nathan PC, Furlong W, Barr RD (2004) Challenges to the measurement of health-related quality of life in children receiving cancer therapy. Pediatr Blood Cancer 43(3):215\u2013223. https:\/\/doi.org\/10.1002\/pbc.20096","journal-title":"Pediatr Blood Cancer"},{"issue":"5 Suppl","key":"639_CR21","first-page":"S94","volume":"120","author":"National Asthma Education and Prevention Program","year":"2007","unstructured":"National Asthma Education and Prevention Program (2007) Expert panel report 3 (EPR-3): guidelines for the diagnosis and management of asthma-summary report 2007. J Allergy Clin Immunol 120(5 Suppl):S94\u2013S138","journal-title":"J Allergy Clin Immunol"},{"issue":"4","key":"639_CR22","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1016\/j.jaci.2006.12.662","volume":"119","author":"AH Liu","year":"2007","unstructured":"Liu AH, Zeiger R, Sorkness C, Mahr T, Ostrom N, Burgess S, Rosenzweig JC, Manjunath R (2007) Development and cross-sectional validation of the childhood asthma control test. J Allergy Clin Immunol 119(4):817\u2013825","journal-title":"J Allergy Clin Immunol"},{"key":"639_CR23","unstructured":"ATLAS.ti.Scientific Software Development GmbH B, Germany (2018) Atlas.ti.software version 8."},{"key":"639_CR24","unstructured":"US Department of Health and Human Services Food and Drug Administration (2021) Clinical Outcome Assessment (COA) Qualification Program: Frequently Asked Questions. https:\/\/www.fda.gov\/drugs\/clinical-outcome-assessment-coa-qualification-program\/clinical-outcome-assessment-coa-qualification-program-frequently-asked-questions#HowCDERPrioritizesSubmissions."},{"issue":"1","key":"639_CR25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s40733-016-0029-3","volume":"3","author":"C Nunes","year":"2017","unstructured":"Nunes C, Pereira AM, Morais-Almeida M (2017) Asthma costs and social impact. Asthma Res Pract 3(1):1. https:\/\/doi.org\/10.1186\/s40733-016-0029-3","journal-title":"Asthma Res Pract"},{"key":"639_CR26","unstructured":"Centers for Disease Control and Prevention (2018) Asthma in children. https:\/\/www.cdc.gov\/vitalsigns\/childhood-asthma\/index.html. 2022"},{"issue":"3","key":"639_CR27","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1097\/01.all.0000225157.67897.c2","volume":"6","author":"H Raat","year":"2006","unstructured":"Raat H, Mohangoo AD, Grootenhuis MA (2006) Pediatric health-related quality of life questionnaires in clinical trials. Curr Opin Allergy Clin Immunol 6(3):180\u2013185. https:\/\/doi.org\/10.1097\/01.all.0000225157.67897.c2","journal-title":"Curr Opin Allergy Clin Immunol"},{"issue":"4","key":"639_CR28","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1586\/erp.10.52","volume":"10","author":"KB Bevans","year":"2010","unstructured":"Bevans KB, Riley AW, Moon J, Forrest CB (2010) Conceptual and methodological advances in child-reported outcomes measurement. Expert Rev Pharmacoecon Outcomes Res 10(4):385\u2013396. https:\/\/doi.org\/10.1586\/erp.10.52","journal-title":"Expert Rev Pharmacoecon Outcomes Res"},{"key":"639_CR29","doi-asserted-by":"crossref","unstructured":"Armstrong BK, White E, Saracci R (1992) Principles of exposure measurement in epidemiology. Oxford University Press. New York, NY","DOI":"10.1093\/oso\/9780192617057.001.0001"},{"issue":"3","key":"639_CR30","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1192\/apt.9.3.229","volume":"9","author":"MX Patel","year":"2003","unstructured":"Patel MX, Doku V, Tennakoon L (2003) Challenges in recruitment of research participants. Adv Psychiatr Treat 9(3):229\u2013238","journal-title":"Adv Psychiatr Treat"},{"issue":"1","key":"639_CR31","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/0090-5720(90)90019-4","volume":"19","author":"EM Hill","year":"1990","unstructured":"Hill EM, Hill MA (1990) Gender differences in child care and work: an interdisciplinary perspective. J Behav Econ 19(1):81\u2013101","journal-title":"J Behav Econ"},{"issue":"1","key":"639_CR32","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1080\/13545701.2010.542004","volume":"17","author":"I Garc\u00eda-Mainar","year":"2011","unstructured":"Garc\u00eda-Mainar I, Molina JA, Montuenga VM (2011) Gender differences in childcare: time allocation in five European countries. Fem Econ 17(1):119\u2013150","journal-title":"Fem Econ"},{"issue":"7","key":"639_CR33","doi-asserted-by":"publisher","first-page":"A718","DOI":"10.1016\/j.jval.2015.09.2718","volume":"18","author":"I Mazar","year":"2015","unstructured":"Mazar I, Lamoureux R, Ojo O, Kevane G, Banderas B, Stokes J, Shields A (2015) Telephone versus face-to-face interviews for patient-reported outcome instrument development. Value Health 18(7):A718","journal-title":"Value Health"},{"issue":"5","key":"639_CR34","first-page":"1292","volume":"25","author":"LM Gray","year":"2020","unstructured":"Gray LM, Wong-Wylie G, Rempel GR, Cook K (2020) Expanding qualitative research interviewing strategies: zoom video communications. Qual Rep 25(5):1292\u20131301","journal-title":"Qual Rep"}],"container-title":["Journal of Patient-Reported Outcomes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s41687-023-00639-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s41687-023-00639-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s41687-023-00639-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,18]],"date-time":"2023-11-18T23:05:58Z","timestamp":1700348758000},"score":1,"resource":{"primary":{"URL":"https:\/\/jpro.springeropen.com\/articles\/10.1186\/s41687-023-00639-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,20]]},"references-count":34,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["639"],"URL":"https:\/\/doi.org\/10.1186\/s41687-023-00639-y","relation":{},"ISSN":["2509-8020"],"issn-type":[{"type":"electronic","value":"2509-8020"}],"subject":[],"published":{"date-parts":[[2023,10,20]]},"assertion":[{"value":"3 January 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 September 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 October 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethical approval and oversight were provided by Copernicus Group Independent Review Board (CGIRB), an independent ethical review board in the U.S. (IRB tracking number: 20200606). All caregiver participants provided informed consent and parental permission (if applicable), and all child participants provided informed assent before participating in any study activities.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Dissemination of findings including via publication was included in the consent and parental permission forms signed by caregivers.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Sonya Eremenco and Stephen Joel Coons are employees of Critical Path Institute, which is the copyright holder for the <i>PAD-C<\/i> and <i>PAD-O<\/i> on behalf of the PRO Consortium. Rob Arbuckle, Rebecca Williams-Hall, Helena Bradley, Amy Jones, Aoife Lydon, and Frances White are employees of Adelphi Values, a health outcomes agency commissioned to conduct research by companies in the pharmaceuticals industry. Adelphi Values received funding from Critical Path Institute to conduct the research summarized in this article. Claire Trennery was an employee of GSK when the research was completed and is now employed by Adelphi Values. Vivian H Shih was an employee of AstraZeneca when the research was conducted and is now employed by Insmed. Erin Tomaszewski is an employee of AstraZeneca. Dr. John Haughney was a consultant of Adelphi Values on behalf of Critical Path Institute as a scientific advisor and received a fee for his involvement. Amanda Eisen and Tonya Winders were consultants of Adelphi Values on behalf of Critical Path Institute as patient advocacy\/caregiver representatives and received a fee for their involvement. Tonya Winders is a paid speaker and advisor to AstraZeneca, Amgen, GSK, Sanofi\/Regeneron and Novartis. The authors declare that there are no other competing interests. Critical Path Institute is supported by the Food and Drug Administration (FDA) of the Department of Health and Human Services (HHS) and is 55% funded by the FDA\/HHS, totaling $17,612,250, and 45% funded by non-government source(s), totaling $14,203,111. The contents are those of the author(s) and do not necessarily represent the official views of, nor an endorsement by, FDA\/HHS or the U.S. Government.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"104"}}